NCT03048760View on ClinicalTrials.gov

Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

January 21, 2019

Study Completion Date

January 21, 2019

Conditions
Lung Cancer
Interventions
OTHER

MRI scan

All participants will undergo 2 MRI scans - 1 at the time of their radiotherapy planning scans \& 1 after approx. 2 weeks of radiotherapy treatment.

Trial Locations (1)

M20 4BX

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

University of Manchester

OTHER

collaborator

Elekta Limited

INDUSTRY

lead

The Christie NHS Foundation Trust

OTHER

NCT03048760 - Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients | Biotech Hunter | Biotech Hunter